20
Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingelheim Am Rhein De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Moxonidine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2003-139 - Rev 00
This Chemical Type CEP, issued on July 29, 2009, remains in force until March 07, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 1758 associated with this CEP further emphasizes